Patent · US Active

Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP

US8524463B2 · kind B2 · utility

11Cited by

0References

20Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Andreas Bergmann · Berlin, DE
Nils Morgenthaler · Berlin, DE
Jana Papassotiriou · Berlin, DE
Joachim Struck · Berlin, DE
Leong Ng · Leicester, GB

Key dates

Filing date	Dec 22, 2007
Grant date	Sep 3, 2013
Priority date	—
Expiry date	Feb 13, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/324
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for diagnosis and/or risk classification for acute coronary syndrome (ACS), in particular for acute myocardial infarct (AMI) and angina pectoris (AP) and/or a post-myocardial infarct, wherein a determination of the C-terminal pro-endothelin (CT-proET-1) or fragments and partial peptides therefrom, is carried out in combination with NT-proBNP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.